
    
      After informed consent and screening, volunteers will be entered into a double blind,
      randomized, three-armed trial, with 40 patients in each group. Patients will receive either
      Naproxen 250 mg daily, Theramine 2 capsules two times daily, or the co-administration of
      low-dose Naproxen 250 mg daily with Theramine 2 capsules two times daily for 28 days.
    
  